TACI-Ig: Phase I data

In a placebo-controlled, dose-escalating, double-blind, U.K. Phase I trial in 23

Read the full 113 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE